tanshinone has been researched along with Brain Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, L; Tan, Y; Wei, S; Xiao, S; Zhang, Z; Zhou, X | 1 |
| Cao, Y; Gao, C; Huang, B | 1 |
| De Feo, V; Di Cesare Mannelli, L; Ferraro, MG; Ghelardini, C; Irace, C; Maione, F; Mascolo, N; Piccolo, M | 1 |
| Kumar, V; Leonardi, D; Radin, D | 1 |
| Dong, L; Guo, H; Liu, C; Wang, L; Wang, X; Yang, L | 1 |
| Jiang, S; Lin, P; Lu, Y; Ren, J; Wang, J; Wang, Q; Wang, X; Wu, Y; Xiong, Z; Yang, H; Yuan, S; Zhang, J | 1 |
| Jiang, S; Lin, P; Ren, JJ; Wang, J; Wang, X; Wu, Y; Xiong, Z; Yang, H; Zhang, J | 1 |
7 other study(ies) available for tanshinone and Brain Neoplasms
| Article | Year |
|---|---|
Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, Death Domain; STAT3 Transcription Factor; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2021 |
Salvia miltiorrhiza extract dihydrotanshinone induces apoptosis and inhibits proliferation of glioma cells.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Cytochromes c; DNA Fragmentation; Dose-Response Relationship, Drug; Glioma; Humans; Plant Extracts; Salvia miltiorrhiza | 2017 |
Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy.
Topics: Abietanes; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glioblastoma; Humans; Male; Mice; Neuralgia; Pain Measurement; Salvia miltiorrhiza | 2018 |
Studies examining the synergy between Dihydrotanshinone and Temozolomide against MGMT+ glioblastoma cells in vitro: Predicting interactions with the blood-brain barrier.
Topics: Abietanes; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Coculture Techniques; DNA Modification Methylases; DNA Repair Enzymes; Drug Synergism; Glioblastoma; Humans; Predictive Value of Tests; Temozolomide; Tumor Suppressor Proteins | 2019 |
Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioma; Humans; Interleukin-6; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2014 |
Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells.
Topics: Abietanes; Analysis of Variance; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Differentiation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glial Fibrillary Acidic Protein; Glioma; Humans; Intermediate Filament Proteins; Nerve Tissue Proteins; Nestin; Phenanthrenes; RNA, Messenger; Statistics, Nonparametric; Tumor Cells, Cultured | 2007 |
Establishment of a new human glioblastoma multiforme cell line (WJ1) and its partial characterization.
Topics: Abietanes; Adult; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Cisplatin; Etoposide; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Intermediate Filament Proteins; Karyotyping; Male; Mice; Mice, Nude; Nerve Tissue Proteins; Nestin; Phenanthrenes; Xenograft Model Antitumor Assays | 2007 |